Nivolumab for second-line treatment of metastatic squamous non-small-cell lung cancer.
about
Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non-small cell lung cancer.N-dihydrogalactochitosan as a potent immune activator for dendritic cells.Potential role of immunotherapy in advanced non-small-cell lung cancerNivolumab as Programmed Death-1 (PD-1) Inhibitor for Targeted Immunotherapy in Tumor.Immune checkpoint blockade as a potential therapeutic target in non-small cell lung cancer.[Initially undetected de novo psoriasis triggered by nivolumab for metastatic base of the tongue carcinoma].High Serum Level of Soluble Programmed Death Ligand 1 is Associated With a Poor Prognosis in Hodgkin Lymphoma.Nivolumab for the treatment of Japanese patients with advanced metastatic non-small cell lung cancer: a review of clinical trial evidence for efficacy and safetyEffective nivolumab sequential thoracic radiotherapy in elderly patients with advanced squamous cell lung cancer: did radiation therapy play a role? A case reportNeoadjuvant PD-1 blockade in lung cancer: we're not in Kansas anymore
P2860
Q33738921-16C4CF47-5C7E-41DE-949F-31DF7ABE5EF2Q36234323-6BA7A7D0-1B8F-4509-B0E8-15B247A52B80Q37527869-BFE29322-8335-4303-938E-E4BDEFDC4699Q37675967-6F7B4EAE-85CD-4CC7-9481-32B4E8D75779Q38899873-D4194AB4-2661-492F-9603-182CC6DF79B2Q50058093-6382CE75-9614-465D-9481-BBB1259DCA9AQ52560940-A46AED71-EECC-4F58-842F-19DB1BCE6C18Q58699010-A4345FDD-6A12-4A8E-B99D-7122FD26A4E6Q58797426-4CC6914C-20EA-4737-8859-C421B1D478FCQ58804468-7393A572-4F57-4986-BCEB-009EF6CF22FE
P2860
Nivolumab for second-line treatment of metastatic squamous non-small-cell lung cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Nivolumab for second-line treatment of metastatic squamous non-small-cell lung cancer.
@en
type
label
Nivolumab for second-line treatment of metastatic squamous non-small-cell lung cancer.
@en
prefLabel
Nivolumab for second-line treatment of metastatic squamous non-small-cell lung cancer.
@en
P356
P1476
Nivolumab for second-line treatment of metastatic squamous non-small-cell lung cancer.
@en
P2093
Amanda Rounds
Jill Kolesar
P304
P356
10.2146/AJHP150235
P577
2015-11-01T00:00:00Z